Expanding antiplatelet use for patients with stroke: The case for stroke of unknown type

Neurology

Volumn 83, Issue 9, 2014, Pages 778-779

  Thrift, Amanda G ^a,b   De Los Rios, Felipe ^c,d  

^a MONASH UNIVERSITY   (Australia)

^b FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^c Department of Neurology Sanna Healthcare Network   (Peru)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL (TOPIC); COMPUTER ASSISTED TOMOGRAPHY; EDITORIAL; FIBRINOLYTIC THERAPY; HUMAN; META ANALYSIS (TOPIC); MORTALITY; NEUROIMAGING; PRIORITY JOURNAL; RECURRENT DISEASE; RISK REDUCTION; STROKE PATIENT; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME; DECISION SUPPORT SYSTEM; FEMALE; MALE; STROKE;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; DECISION SUPPORT TECHNIQUES; FEMALE; HUMANS; MALE; STROKE;

EID: 84921966917     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000000744     Document Type: Editorial

References (10)

1. Feigin VL, ForouzanfarMH, Krishnamurthi R, et al. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet 2014;383:245-254.
2. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380: 2095-2128.
3. Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2197-2223.
4. Chen Z, Sandercock P, Pan H, et al; on behalf of the CAST and IST collaborative groups. Indications for early aspirin use in acute ischemic stroke: A combined analysis of 40, 000 randomized patients from the Chinese Acute Stroke Trial and the International Stroke Trial. Stroke 2000;31:1240-1249.
5. Sridharan SE, Unnikrishnan JP, Sukumaran S, et al. Incidence, types, risk factors, and outcome of stroke in a developing country: The Trivandrum Stroke Registry. Stroke 2009;40:1212-1218.
6. Kolapo KO, Ogun SA, Danesi MA, Osalusi BS, Odusote KA. Validation study of the Siriraj Stroke Score in African Nigerians and evaluation of the discriminant values of its parameters: A preliminary prospective CT scan study. Stroke 2006;37:1997-2000.
7. Lloyd-Sherlock P. Stroke in developing countries: epidemiology, impact and policy implications. Development Policy Rev 2010;28:693-709.
8. Berkowitz AL, Westover MB, Bianchi MT, Chou SHY. Aspirin for acute stroke of unknown etiology in resourcelimited settings: A decision analysis. Neurology 2014;83: 787-793.
9. Garbusinski JM, van der Sande MA, Bartholome EJ, et al. Stroke presentation and outcome in developing countries: A prospective study in the Gambia. Stroke 2005;36: 1388-1393.
10. Runchey S, McGee S. Does this patient have a hemorrhagic stroke? Clinical findings distinguishing hemorrhagic stroke from ischemic stroke. JAMA 2010;303:2280-2286.